Cell Therapeutics (CTIC) finishes the day up nearly 15% after saying earlier this morning that...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC) finishes the day up nearly 15% after saying earlier this morning that it's expecting the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) to release its opinion on the company's Marketing Authorization Application for Pixuvri in mid-February.